NCT01810315View on ClinicalTrials.gov

Influence of Reproductive Cycle and Menopause on HIV-1 Infection and TFV Gel Activity

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
HIV Prevention
Interventions
DRUG

TFV 1% gel

DRUG

Estradiol vaginal cream

Trial Locations (1)

23507

Clinical Research Center, Eastern Virginia Medical School, Norfolk

All Listed Sponsors
lead

CONRAD

OTHER

NCT01810315 - Influence of Reproductive Cycle and Menopause on HIV-1 Infection and TFV Gel Activity | Biotech Hunter | Biotech Hunter